Ledger.Open graph →
SEC Form D · filed May 22, 2018

CiVi Biopharma Holdings, Inc

Offering
$49.0M
Sold
$49.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRYN MAWR, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Christopher Fuglesang · Bryn Mawr, PADirectorShalom Jacobovitz · Bryn Mawr, PAExec · DirectorCarole Nuechterlein · Bryn Mawr, PADirectorAaron Davis · Bryn Mawr, PADirectorHenrik Oerum · Bryn Mawr, PAExec · DirectorChristopher Fuglesang · Bryn Mawr, PADirectorAaron Davis · Bryn Mawr, PADirectorHenrik Oerum · Bryn Mawr, PAExec · DirectorShalom Jacobovitz · Bryn Mawr, PAExec · DirectorCarole Nuechterlein · Bryn Mawr, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗